• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胎盘期失血预防的副作用]

[The side effects of the prevention of blood loss in the placental period].

作者信息

Dimitrov A, Nalbanski B, Borisov S, Nikolov A, Dzherov L, Gamishev G

出版信息

Akush Ginekol (Sofiia). 1996;35(3):11-3.

PMID:9045547
Abstract

On the base of 192 retrospective and 144 prospective cases are evaluated the side of routine prophylactic of the blood loss at the third period of labor. The control group consist of 50 labouring women with expective management of placental period. In normotensive women the methergine does not increase the blood pressure. The use of oxytocic drugs after the delivery of the head shorten the time of placental separation but make more difficult the cord traction method for the delivery of the placenta. The active management of the placental period decrease the rate of instrumental revision of the uterine cavity and the supplemental administration of oxytocic in the early postpartum period. This investigation confirms and justify the routine use of oxytocic after the delivery of the head as a prophylactic of the blood loss in the placental period.

摘要

基于192例回顾性病例和144例前瞻性病例,对分娩第三产程失血的常规预防措施进行了评估。对照组由50名采用期待处理胎盘期的产妇组成。在血压正常的女性中,麦角新碱不会升高血压。胎头娩出后使用催产药物可缩短胎盘剥离时间,但会使胎盘娩出时的脐带牵引方法更困难。积极处理胎盘期可降低宫腔器械检查率及产后早期催产药物的补充使用。本研究证实并说明了胎头娩出后常规使用催产药物作为胎盘期失血预防措施的合理性。

相似文献

1
[The side effects of the prevention of blood loss in the placental period].[胎盘期失血预防的副作用]
Akush Ginekol (Sofiia). 1996;35(3):11-3.
2
[Blood loss in the placental period in relation to the type of prophylaxis].[胎盘期失血与预防类型的关系]
Akush Ginekol (Sofiia). 1996;35(3):9-11.
3
The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor.索尔福德第三阶段试验。缩宫素加麦角新碱与单纯缩宫素用于第三产程的积极处理
Online J Curr Clin Trials. 1993 Aug 13;Doc No 83:[2305 words; 32 paragraphs].
4
Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.宫缩剂预防产后出血:缩宫素与甲基麦角新碱在第三产程管理中的比较
Acta Obstet Gynecol Scand. 2006;85(11):1310-4. doi: 10.1080/00016340600756912.
5
[The choice of the uterine-contraction agent in managing the placental period of labor based on our data].基于我们的数据选择子宫收缩剂用于处理分娩后胎盘娩出期
Akush Ginekol (Sofiia). 1998;37(2):4-6.
6
Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage.肌肉注射麦角新碱与肌肉注射缩宫素预防产后出血的前瞻性研究。
J Obstet Gynaecol Res. 2007 Jun;33(3):254-8. doi: 10.1111/j.1447-0756.2007.00520.x.
7
Randomized comparison of rectal misoprostol with Syntometrine for management of third stage of labor.米索前列醇直肠给药与欣母沛用于分娩第三产程管理的随机对照研究
Acta Obstet Gynecol Scand. 1998 Feb;77(2):178-81.
8
Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor.口服米索前列醇预防第三产程原发性产后出血。
J Obstet Gynaecol Res. 2007 Dec;33(6):810-7. doi: 10.1111/j.1447-0756.2007.00661.x.
9
Active pharmacologic management of the third stage of labor. A comparison of oxytocin and ergometrine.第三产程的积极药物管理:缩宫素与麦角新碱的比较
Obstet Gynecol. 1978 Dec;52(6):694-7.
10
Prevention of postpartum hemorrhage, safety and efficacy.产后出血的预防、安全性及有效性。
Saudi Med J. 2001 Dec;22(12):1118-21.